SOBRsafe Regains Compliance with Nasdaq Listing Requirements

Stock Information for Eagle Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eagle Pharmaceuticals Inc.

Amid Surgeon General's Warning on Alcohol and Cancer, Middle-Aged Women Rethink Drinking
SOBRsafe Announces Reverse Stock Split
SOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable Technology
SOBRsafe Launches Revolutionary Alcohol Detection Software: Transforming Patient Care for Behavioral Health Providers
Aegis Capital Corp. acted as Exclusive Placement Agent on an $8.2 Million Private Placement for SOBR Safe, Inc. (NASDAQ:SOBR)
SOBRsafe Announces Closing of $8.2 Million Private Placement
SOBRsafe Announces Pricing of $8.2 Million Private Placement
India, Italy and Australia: SOBRsafe Provides International Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.